![Gary Titus](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Titus
Direttore/Membro del Consiglio presso
BioSight Ltd.
Profilo
Gary S.
Titus is currently a Director at BioSight Ltd. He previously worked as a Senior Finance Director at IntraBiotics Pharmaceuticals, Inc. and CymaBay Therapeutics, Inc. He was also the Chief Financial Officer & Senior Vice President at SciClone Pharmaceuticals LLC, Chief Financial & Accounting Officer, VP at Nuvelo, Inc., and Chief Financial Officer & Senior Vice President at Kosan Biosciences, Inc. He served as an Independent Director at ImmunoCellular Therapeutics Ltd. and was the Chief Financial Officer at BioCardia, Inc. and UroGen Pharma Ltd. He holds an undergraduate degree from the University of Florida and the University of South Florida.
Posizioni attive di Gary Titus
| Società | Posizione | Inizio |
|---|---|---|
BioSight Ltd.
 BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Gary Titus
| Società | Posizione | Fine |
|---|---|---|
| PLUS THERAPEUTICS, INC. | Direttore Finanziario/CFO | 05/07/2019 |
| UROGEN PHARMA LTD. | Direttore Finanziario/CFO | 05/06/2018 |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Direttore Finanziario/CFO | 01/01/2015 |
| SCICLONE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 31/05/2013 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Direttore Finanziario/CFO | 01/09/2008 |
Formazione di Gary Titus
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
69
Relazioni di 1° grado
13
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 13 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
SciClone Pharmaceuticals LLC
 SciClone Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer and infectious diseases | Health Technology |
Nuvelo, Inc.
 Nuvelo, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs using genomic technologies | Health Technology |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial and antifungal drugs | Health Technology |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for cancer therapeutics | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
ImmunoCellular Therapeutics Ltd.
 ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of South Florida
 University of South Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
BioCardia, Inc. /Old/
BioCardia, Inc. /Old/ BiotechnologyHealth Technology Operates as a clinical-stage company that engages in the development of regenerative medicine and novel therapeutics for cardiovascular diseases | Health Technology |
BioSight Ltd.
BioSight Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotech pharmaceutical company that provides cancer drug development services | Health Technology |
UroGen Pharma Ltd.
 UroGen Pharma Ltd. BiotechnologyHealth Technology Develops therapies for urological pathologies | Health Technology |
